DanielRobertBensimhonMD
Cardiology • Greensboro, NCAdult Congenital Heart Disease, Heart Failure & Transplantation
Medical Director, Advanced Heart Failure & Mechanical Circulatory Support Program
Dr. Bensimhon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1200 N Elm St
Ste 1982
Greensboro, NC 27401Phone+1 336-832-9292Fax+1 336-851-8427
Education & Training
Duke University HospitalFellowship, Cardiovascular Disease, 2001 - 2004- Duke University HospitalResidency, Internal Medicine, 1998 - 2001
University of Pittsburgh School of MedicineClass of 1998
Certifications & Licensure
ID State Medical License 2022 - 2026
MO State Medical License 2022 - 2026
MI State Medical License 2020 - 2026
MA State Medical License 2023 - 2026
RI State Medical License 2022 - 2026
AK State Medical License 2022 - 2026
ND State Medical License 2022 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
- American Board of Internal Medicine Cardiovascular Disease
- Join now to see all
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Guiding Evidence Based Therapy Using Biomarker Intensified Treatment Start of enrollment: 2012 Dec 01
Publications & Presentations
PubMed
- 1 citationsRandomized Study Comparing a Novel Intranasal Formulation of Bumetanide to Oral and Intravenous Formulations.Andrew P Ambrosy, Daniel Bensimhon, Galina Bernstein, Brian Kolski, Joel Neutel
Circulation. 2024-11-18 - 1 citationsHeart failure management at home: a non-randomised prospective case-controlled trial (HeMan at Home).Justin Helberg, Daniel Bensimhon, Vasili Katsadouros, Michelle Schmerge, Heather Smith
Open Heart. 2023-12-07 - 3 citationsA novel opportunity to improve heart failure care: focusing on subcutaneous furosemide.Wahab J Khan, Jose Arriola-Montenegro, Melinda S Mutschler, Daniel Bensimhon, Robert Halmosi
Heart Failure Reviews. 2023-11-01
Journal Articles
- Use of ReDS Technology to Triage Heart Failure Patients in the Emergency DepartmentDaniel Bensimhon, MD, Journal of Cardiac Failure
Press Mentions
AHA: Bumetanide Nasal Spray Statistically Bioequivalent to Oral BumetanideNovember 26th, 2024- RSQ-777-02: New Nasal Spray Form of Bumetanide as Effective as Oral and IV Forms in Patients Without HF or HF RiskNovember 18th, 2024
- Nasal Spray Version of Common Diuretic Has Potential to Help Treat Heart FailureNovember 18th, 2024
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
